We advise a wide range of pharmaceutical and biotech clients from young startups to some of the world’s largest, most well-established companies.
As a result we have considerable experience not only of the headline issues but of the specific practical challenges and opportunities arising for the different players in this space. We frequently advise on licensing, collaboration agreements and joint ventures, including with universities, and we have extensive experience of advising companies in these sectors on the full range of IP issues including patents, trade marks, litigation and dispute resolution. Our strong competition-law and regulatory teams also regularly act for life sciences companies on relevant issues including market authorisations, advertising and pricing. On the corporate side we often act on acquisitions in the pharmaceutical and biotech spheres and on financing transactions.